Concentration is not a dose
The listed concentration is 3 mg/mL. Follow only your prescription’s route, dose, and schedule; this page provides no dosing or syringe-unit conversion instructions.
BPC-157 · 3 mg/mLBPC-157.
3 mg/mL
An informed conversation.
Discuss BPC-157 with a licensed clinician, including the limited human evidence, potential risks, and whether any treatment is appropriate for your needs.
BPC-157 PRICING
- Product type
- Compounded prescription
- Concentration
- 3 mg/mL
- FDA status
- Not FDA-approved
- Eligibility
- Determined by a licensed clinician
Prescription only; clinical approval and pharmacy availability required. An evaluation does not guarantee a prescription. BPC-157 is not FDA-approved.
Important safety & evidence informationUNDERSTAND THE EVIDENCE
Research.
Not a guarantee.
BPC-157 is an investigational peptide—not an FDA-approved treatment.
BPC-157 is a synthetic peptide comprising 15 amino acids. It has been studied in laboratory and animal research involving tissue responses. These findings do not establish that it heals injuries, improves recovery, or treats a condition in people. Human clinical evidence remains limited.
WHAT DOES 3 MG/ML MEAN?
This is the concentration of the listed formulation, not a dose or a treatment schedule. Your prescription and pharmacy label determine how the medication is used. Do not infer a dose, package volume, or quantity from the concentration or the illustrative image.
Evidence background: FDA BPC-157 scientific review (PDF). This review is not an approval or a prescribing guide.
HOW IT WORKS
Care comes first.
A medical evaluation starts a conversation. It does not establish eligibility or make treatment automatic.
- STEP 01 / SHARE YOUR HISTORY
Start with your story.
Complete the peptides intake with your health history, symptoms, current medications, and goals. Tell the clinician about previous treatments and any questions about BPC-157.
- STEP 02 / CLINICIAN REVIEW
Consider the options.
A licensed clinician reviews your information, discusses uncertainties and alternatives, and decides whether any prescription is appropriate. Further information or an in-person assessment may be needed.
- STEP 03 / YOUR NEXT STEPS
Confirm your plan.
If prescribed, review the pharmacy label, instructions, monitoring, and follow-up with your care team. Ask questions before using a medication or changing treatment.
BEFORE YOU BEGIN
Know your plan.
The clinician and dispensing pharmacist confirm the details of your own prescription.
Handling & storage
Use the directions supplied with your exact formulation. Confirm its storage requirements, expiration or beyond-use date, and handling instructions with the pharmacy. Do not substitute another product’s instructions.
Billing & treatment are separate
Monthly billing is $199; quarterly billing is $459 every 3 months. A billing interval is not a recommendation for a treatment duration. Review quantities, inclusions, renewals, and cancellation terms during enrollment.
Availability is individual
A product listing is not a guarantee of prescribing or dispensing in your state. Review our Compliance page, Cancellation Policy, and Refund Policy.
READ BEFORE CONSIDERING TREATMENT
Important safety information.
BPC-157’s safety profile is not well established. This page is educational, not complete prescribing information or a recommendation to use it.
Not FDA-approved.
Compounded BPC-157 has not undergone FDA premarket review for safety, effectiveness, or quality. HHS’s interim compounding policy describes conditional enforcement discretion; it is not drug approval or a finding that BPC-157 is safe or effective. The clinician and pharmacy must assess applicable requirements for each prescription.
Read the HHS interim policy (PDF)LIMITED HUMAN SAFETY INFORMATION
Important unknowns remain.
FDA identifies potential immune-reaction risks and concerns about peptide impurities and ingredient characterization. Limited safety information means the frequency and full range of adverse effects—including long-term risks—are not established.
Discuss your full history
Tell your clinician about your medical conditions, allergies, medications, supplements, and previous reactions. Discuss pregnancy, pregnancy plans, or breastfeeding before considering treatment. Do not assume that missing safety data means a product is safe for you.
Contact your care team promptly about new or concerning symptoms. Seek urgent medical care for breathing difficulty, face or throat swelling, or other signs of a serious allergic reaction. Call 911 for a medical emergency.
Competitive athletes
BPC-157 is prohibited at all times under section S0 of the 2026 WADA Prohibited List. A prescription does not automatically establish permission under anti-doping rules. Check with your sport’s anti-doping organization before considering it.
Sources checked November 11, 2026: FDA scientific review (PDF), HHS compounding policy (PDF), and WADA 2026 list (PDF). Regulatory policies can change; your care team must verify current requirements.
How much does BPC-157 cost?
BPC-157 3 mg/mL is $199 per month with monthly billing, or $459 per quarter, billed every 3 months. The quarterly option is equivalent to $153 per month. Review the offer, quantities, and billing terms presented during enrollment before agreeing.
Is BPC-157 FDA-approved?
No. BPC-157 is not FDA-approved. Conditional compounding policies and a clinician’s prescription do not change that status. Review the safety and compounding information above.
Does BPC-157 heal injuries or improve recovery?
Those benefits are not established by adequate human evidence. Laboratory or animal findings should not be treated as proof of clinical benefit. Discuss your symptoms and evidence-based options with a licensed clinician.
What does 3 mg/mL tell me?
It describes concentration, not the dose, total amount in a container, or how often to use it. Only your clinician’s prescription and pharmacy instructions establish your individual plan.
Does quarterly billing mean three months of treatment?
No treatment duration is recommended by the billing label. Your clinician determines any treatment plan and follow-up. Confirm quantities, what is included, renewal terms, and cancellation conditions before enrollment.
Can competitive athletes use BPC-157?
The 2026 WADA list prohibits BPC-157 in and out of competition under S0. Athletes subject to anti-doping rules should consult their anti-doping organization; a prescription is not automatic permission.
Who decides whether a prescription is appropriate?
A licensed clinician makes that decision following an individual evaluation. They may recommend another approach, additional testing, in-person care, or no medication. Completing an intake does not guarantee a prescription.
YOUR NEXT STEP
Start a conversation.
Make an informed decision.
Share your health history and questions with a licensed clinician.
Start your evaluation
Prescription only. Subject to clinical approval.